Functional scales: Pro

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 3, Issue SUPPL. 1, 2002, Pages

  Mora, Gabriele ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LUNG FUNCTION; MUSCLE STRENGTH; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SURVIVAL;

EID: 0036393431     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608202320374147     Document Type: Article

References (5)

1. Norris FH, Calanchini PR, Fallat R, Panchri S, Jewett BJ. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1979; 24: 721-728.
2. Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8: 142-150.
3. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987; 22: 328-333.
4. ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (RHCNTF) in patients with amyotrophic lateral sclerosis - Relation to parameters of the acute-phase response. Clin Neuropharmacol 1995; 18: 500-514.
5. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantative motor assessment in amyotrophic lateral sclerosis. Neurology 1986; 36: 937-941.